SPX5,638.94+117.42 2.13%
DIA415.36+6.58 1.61%
IXIC17,754.09+451.07 2.61%

Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $16

Benzinga·03/04/2025 16:51:44
Listen to the news
Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target from $22 to $16.